Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial — Vassilis Georgoulias (1999) | RDL Network
Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial
Article 1999 en
Authors
VG
Vassilis Georgoulias
CK
Charalambos Kouroussis
NA
N. Androulakis
Abstract
1 min read
The combination of docetaxel/gemcitabine is well tolerated, can be used for outpatients, and is active for the treatment of advanced NSCLC. This treatment merits further comparison with other cisplatin- or carboplatin-based combinations.
Vassilis Georgoulias, C. Kourousis, Stylianos Kakolyris, N. Androulakis, Meletios A Dimopoulos, E. Papadakis, Thanos Kotsakis, N. Vardakis, K. Kalbakis, N. Merambeliotakis, Dora Hatzidaki
Vassilis Georgoulias, C. Kourousis, N. Androulakis, S. Kakolyris, Meletios A Dimopoulos, Demosthenes Bouros, C. Papadimitriou, Kostas Hatzakis, P. Heras, K. Kalbakis, Thanos Kotsakis, N. Vardakis, N. Meramveliotakis, Dora Hatzidaki
P. Kosmidis, Haralabos P. Kalofonos, K. Syrigos, D. Skarlos, George Fountzilas, C. Nicolaides, D. Bafaloukos, E. Samantas, C. Bakogiannis, Meletios A Dimopoulos
P. Kosmidis, Nick Mylonakis, C. Nicolaides, C. Kalophonos, Epaminontas Samantas, J. Boukovinas, George Fountzilas, Dimosthenis Skarlos, T. Economopoulos, D. Tsavdaridis, Pavlos Papakostas, C. Bacoyiannis, Meletios A Dimopoulos
Vassilis Georgoulias, Ch Kourousis, N. Androulakis, S. Kakolyris, Meletios A Dimopoulos, E. Papadakis, Demosthenes Bouros, F Apostolopoulou, C Papadimitriou, Athina Agelidou, V Tzianni, F Apostolaki, Kostas Hatzakis, K. Kalbakis, Α. Kotsakis, E. Sarra, N. Vardakis, J. Vlachonicolis
Discussion(0)
No comments yet. Be the first to comment.